» Articles » PMID: 33519923

Identification of Common Genes and Pathways in Eight Fibrosis Diseases

Overview
Journal Front Genet
Date 2021 Feb 1
PMID 33519923
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Acute and chronic inflammation often leads to fibrosis, which is also the common and final pathological outcome of chronic inflammatory diseases. To explore the common genes and pathogenic pathways among different fibrotic diseases, we collected all the reported genes of the eight fibrotic diseases: eye fibrosis, heart fibrosis, hepatic fibrosis, intestinal fibrosis, lung fibrosis, pancreas fibrosis, renal fibrosis, and skin fibrosis. We calculated the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) enrichment scores of all fibrotic disease genes. Each gene was encoded using KEGG and GO enrichment scores, which reflected how much a gene can affect this function. For each fibrotic disease, by comparing the KEGG and GO enrichment scores between reported disease genes and other genes using the Monte Carlo feature selection (MCFS) method, the key KEGG and GO features were identified. We compared the gene overlaps among eight fibrotic diseases and connective tissue growth factor (CTGF) was finally identified as the common key molecule. The key KEGG and GO features of the eight fibrotic diseases were all screened by MCFS method. Moreover, we interestingly found overlaps of pathways between renal fibrosis and skin fibrosis, such as GO:1901890-positive regulation of cell junction assembly, as well as common regulatory genes, such as CTGF, which is the key molecule regulating fibrogenesis. We hope to offer a new insight into the cellular and molecular mechanisms underlying fibrosis and therefore help leading to the development of new drugs, which specifically delay or even improve the symptoms of fibrosis.

Citing Articles

Modified bFGF targeting connective tissue growth factor in the injured microenvironment improved cardiac repair after chronic myocardial ischemia.

Sun S, Zhu F, Xu Q, Hou X, Nie W, Su K Regen Ther. 2025; 28:438-450.

PMID: 39925966 PMC: 11803136. DOI: 10.1016/j.reth.2025.01.006.


CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.

Kashyap M, Mishra B, Sinha R, Jin L, Gou Y, Kumar N Proc Natl Acad Sci U S A. 2024; 121(48):e2409274121.

PMID: 39560648 PMC: 11621750. DOI: 10.1073/pnas.2409274121.


Targeting pathogenic CD8 tissue-resident T cells with chimeric antigen receptor therapy in murine autoimmune cholangitis.

Zhu H, Yang S, Gao C, Bian Z, Chen X, Huang R Nat Commun. 2024; 15(1):2936.

PMID: 38580644 PMC: 10997620. DOI: 10.1038/s41467-024-46654-5.


Somatic mutations reveal hyperactive Notch signaling and racial disparities in prurigo nodularis.

Rajeh A, Cornman H, Gupta A, Szeto M, Kambala A, Oladipo O medRxiv. 2023; .

PMID: 37808834 PMC: 10557842. DOI: 10.1101/2023.09.25.23295810.


Targeting cullin neddylation for cancer and fibrotic diseases.

He Z, Yang W, Zengyangzong D, Gao G, Zhang Q, Liu H Theranostics. 2023; 13(14):5017-5056.

PMID: 37771770 PMC: 10526667. DOI: 10.7150/thno.78876.


References
1.
Das S, Gupta I, Cho Y, Zhang X, Uehara H, Muddana S . Vimentin knockdown decreases corneal opacity. Invest Ophthalmol Vis Sci. 2014; 55(7):4030-40. PMC: 4078947. DOI: 10.1167/iovs.13-13494. View

2.
Chen L, Pan X, Guo W, Gan Z, Zhang Y, Niu Z . Investigating the gene expression profiles of cells in seven embryonic stages with machine learning algorithms. Genomics. 2020; 112(3):2524-2534. DOI: 10.1016/j.ygeno.2020.02.004. View

3.
Kanno Y, Shu E, Kanoh H, Matsuda A, Seishima M . α2AP regulates vascular alteration by inhibiting VEGF signaling in systemic sclerosis: the roles of α2AP in vascular dysfunction in systemic sclerosis. Arthritis Res Ther. 2017; 19(1):22. PMC: 5291960. DOI: 10.1186/s13075-017-1227-y. View

4.
Sieber P, Schafer A, Lieberherr R, Le Goff F, Stritt M, Welford R . Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors. PLoS One. 2018; 13(11):e0207872. PMC: 6261607. DOI: 10.1371/journal.pone.0207872. View

5.
Madahar P, Duprez D, Podolanczuk A, Bernstein E, Kawut S, Raghu G . Collagen biomarkers and subclinical interstitial lung disease: The Multi-Ethnic Study of Atherosclerosis. Respir Med. 2018; 140:108-114. PMC: 6310068. DOI: 10.1016/j.rmed.2018.06.001. View